Los puntos clave no están disponibles para este artículo en este momento.
Risk of developing comorbidities is increased in survivors of AYA cancer compared with the general population. Specific cancer treatment exposures were associated with risk of developing different comorbidities. These findings have important implications for survivorship care planning and patient education.
Chao et al. (Thu,) studied this question.